In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting vaccines, and more.
ByAmy Feldman,
Forbes Staff
andAlex Knapp,
Forbes Staff.
In this week’s edition of InnovationRx, we look at the price cuts for blockbuster weight-loss drugs, the Forbes 30 Under 30 Healthcare list, the coming barriers to getting vaccines, and more. To get it in your inbox, subscribe here.
In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…
The connection between weight loss drugs, jet fuel and the software sell-off explained.
The deal, which includes Eli Lilly and Novo Nordisk, will slash prices for Medicare and Medicaid programme recipients.
Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in…
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward…
The growing, deadly plague of counterfeit drugs demands smarter, targeted enforcement.
